Navigation Links
Nanomedicines' impact on patients under the microscope
Date:5/29/2013

A pioneering imaging technique to track the effects of next-generation nanomedicines on patients has been harnessed by a University of Strathclyde academic.

Professor Dr. M. N. V. Ravi Kumar and Dr. Dimitrios Lamprou, of the Strathclyde Institute of Pharmacy and Biomedical Sciences, believe an advanced form of atomic force microscopy, known as PeakForce QNM, could boost developments in the field of nanomedicines, the encapsulation of potent drugs in tiny particles measuring billionths of a meter in diameter. They described how this detailed imaging approach may also help scientists address growing concerns in the medical world around "nanotoxicology", the build-up of microscopic particles in people's tissues.

Professor Kumar, whose team's research article has been published in the journal PLOS ONE, said: "Nanotechnology's role in drug delivery has the power to transform the way patients are given medicines over the next decade or so.

"In the case of traditional medicines, such as tablets and capsules, only a limited amount of drug thought to be around five to 15 per cent for the majority of compounds makes it through the gut into patients' blood. The good thing about nanomedicines is that unlike as is the case with traditional tablets and capsules the drugs are not released in the gut. Instead, nanomedicines are absorbed intact and release the encapsulated drugs directly into bodily tissues, including the blood, offering the possibility to reduce the required dose without compromising the therapeutic effects.

"All medicines are combined with what are known as 'excipients' inactive substances which give them the desired bulk and consistency and their role is restricted to the gut. However, the excipients such as polymers, used to formulate the nanoparticle-encapsulating drugs may exhibit undesired effects when they are absorbed through the gut wall. Scientists want to know if nanoparticle-based drugs can have any adverse effects on patients and, in particular, if they cause more harm than good in some cases.

"Up until now, little has been known about what happens after nanoparticles circulate throughout the body and if they raise any safety issues for the patient. Previously, it was necessary for nanoparticles to be given a fluorescent or radioactive label, in order to allow scientists to be able to identify and track them. However, by using PeakForce QNM atomic force microscopy we can, for the first time, track where these nanoparticles are going throughout the body after oral administration without attaching any fluorescent or radioactive labels and by using the real drug loaded nanoparticles. In particular, we can identify if they are accumulating in specific areas, causing what is known as 'tissue stiffness' a condition linked to a variety of diseases, including cancer."

Professor Kumar said it is known that tumours are more rigid or stiff when compared with surrounding healthy tissues. In addition, recent studies using atomic force microscopy have also shown it is possible to distinguish between non-malignant and malignant tumours cells, on the basis of their relative stiffness.

Professor Kumar added: "The ability of atomic force microscopy to study biomechanical profiles will be an asset in efforts to better understand the difference in tissue stiffness between tissues treated with nanoparticles and those not treated with nanoparticles, how long any associated tissue stiffness persists, and if it disappears quickly. Importantly, it will also help to establish whether or not there is a correlation between the number of nanoparticles present in blood and their accumulation in other tissues. By understanding more about blood stiffness, we will be able to learn more about nanotoxicology generally, and how that affects patients.

"By using atomic force microscopy in this way, we may in future be able to analyse patients' blood and tell if, for example, nanomaterials are accumulating in their livers or arterial walls, causing stiffness which if it persists long enough may increase their chances of developing diseases.

"Another benefit of nanoparticles is that if used at an early stage of the research they could save pharmaceutical firms money by reducing the number of drugs that fail at the development stage. These cost savings could then be reinvested into the research and development of new drugs to treat patients."


'/>"/>
Contact: Corporate Communications
corporatecomms@strath.ac.uk
44-014-154-82370
University of Strathclyde
Source:Eurekalert

Related biology news :

1. New study will help protect vulnerable birds from impacts of climate change
2. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
3. Research on flavanols and procyanidins provides new insights into how these phytonutrients may positively impact human health
4. Study by Haverford College professor reveals unprecedented impact of Deepwater Horizon on deep ocean
5. New UH lecture series examines impact of science on health
6. Impact of warming climate doesnt always translate to streamflow
7. Large international study finds memory in adults impacted by versions of 4 genes
8. Fracking and Health Impact Assessments -- IOM hosts workshop April 30 and May 1
9. Selenium impacts honey bee behavior and survival
10. NASA satellite measurements imply Texas wind farm impact on surface temperature
11. A small cut with a big impact
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/21/2016)... VANCOUVER, British Columbia , June 21, 2016 ... been appointed to the new role of principal ... has been named the director of customer development. ... , NuData,s chief technical officer. The moves reflect ... development teams in response to high customer demand ...
(Date:6/9/2016)... , June 9, 2016 ... Police deploy Teleste,s video security solution to ensure the safety ... France during the major tournament Teleste, ... communications systems and services, announced today that its video security ... to back up public safety across the country. ...
(Date:6/2/2016)... Perimeter Surveillance & Detection Systems, Biometrics & ... & Other Service  The latest report from ... of the global Border Security market . Visiongain ... billion in 2016. Now: In November 2015 ... and hardware technologies for advanced video surveillance. ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
Breaking Biology Technology: